(Q74492643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

ORCID Public Data File 2021

author name string

P Sendi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A J Palmer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Gafni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Battegay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

709-713

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548908%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-200119070-00001

11 November 2019

exact match

0 references

cites work

Accounting for future costs in medical cost-effectiveness analysis

1 reference

12 December 2020

Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy

1 reference

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Cost-effectiveness ratios: in a league of their own.

1 reference

12 December 2020

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

1 reference

12 December 2020

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

1 reference

12 December 2020

Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.

1 reference

12 December 2020

Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

1 reference

12 December 2020

Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center

1 reference

12 December 2020

Discounting in the economic evaluation of health care interventions

1 reference

12 December 2020

Cost effectiveness of combination HIV therapy: 3 years later

1 reference

12 December 2020

Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus

1 reference

12 December 2020

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens

1 reference

12 December 2020

Reduction in human immunodeficiency virus patient hospitalizations and nontraumatic mortality after adoption of highly active antiretroviral therapy

1 reference

12 December 2020

The cost effectiveness of antiretroviral regimens for the treatment of HIV/AIDS.

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort Study

1 reference

12 December 2020

Combination antiretroviral therapy in HIV infection. An economic perspective

1 reference

12 December 2020

Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.

1 reference

12 December 2020

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

12 December 2020